Treatment and Prognosis of Facial Palsy on Ramsay Hunt Syndrome: Results Based on a Review of the Literature

Imagem de Miniatura
Arquivos
art_MONSANTO_Treatment_and_Prognosis_of_Facial_Palsy_on_Ramsay_2016.PDF (221.59 KB)
Citações na Scopus
55
Tipo de produção
article
Data de publicação
2016
DOI
SciELO
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
Fundação Otorrinolaringologia
Autores
MONSANTO, Rafael da Costa
BOBATO NETO, Natal José
BEILKE, Silvia Carolina Almeida
LORENZETTI, Fabio Tadeu Moura
Citação
INTERNATIONAL ARCHIVES OF OTORHINOLARYNGOLOGY, v.20, n.4, p.394-400, 2016
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Abstract Introduction Ramsay Hunt syndrome is the second most common cause of facial palsy. Early and correct treatment should be performed to avoid complications, such as permanent facial nerve dysfunction. Objective The objective of this study is to review the prognosis of the facial palsy on Ramsay Hunt syndrome, considering the different treatments proposed in the literature. Data Synthesis We read the abstract of 78 studies; we selected 31 studies and read them in full. We selected 19 studies for appraisal. Among the 882 selected patients, 621 (70.4%) achieved a House-Brackmann score of I or II; 68% of the patients treated only with steroids achieved HB I or II, versus 70.5% when treated with steroids plus antiviral agents. Among patients with complete facial palsy (grades V or VI), 51.4% recovered to grades I or II. The rate of complete recovery varied considering the steroid associated with acyclovir: 81.3% for methylprednisolone, 69.2% for prednisone; 61.4% for prednisolone; and 76.3% for hydrocortisone. Conclusions Patients with Ramsay-hunt syndrome, when early diagnosed and treated, achieve high rates of complete recovery. The association of steroids and acyclovir is better than steroids used in monotherapy.
Palavras-chave
prognosis, facial palsy, ramsay hunt syndrome, varicela zoster, house-brackmann
URI
https://observatorio.fm.usp.br/handle/OPI/18215
Referências
  1. Bodenez C, 2010, J LARYNGOL OTOL, V124, P272, DOI 10.1017/S0022215109991265
  2. Boemo Rafael Luis, 2010, Acta Otorrinolaringol Esp, V61, P418, DOI 10.1016/j.otorri.2010.07.004
  3. Coulson S, 2011, OTOL NEUROTOL, V32, P1025, DOI 10.1097/MAO.0b013e3182255727
  4. de Ru JA, 2011, OTOL NEUROTOL, V32, P852, DOI 10.1097/MAO.0b013e31821a00e5
  5. Donati D, 2012, J NEUROL SCI, V318, P160, DOI 10.1016/j.jns.2012.04.011
  6. Furuta Y, 2004, ANN OTO RHINOL LARYN, V113, P700
  7. Gilchrist JM, 2009, SEMIN NEUROL, V29, P5, DOI 10.1055/s-0028-1124018
  8. Gondivkar Shailesh, 2010, Contemp Clin Dent, V1, P127, DOI 10.4103/0976-237X.68588
  9. Kansu L, 2012, INT J PEDIATR OTORHI, V76, P772, DOI 10.1016/j.ijporl.2012.03.003
  10. Kim YH, 2010, LARYNGOSCOPE, V120, P2270, DOI 10.1002/lary.21108
  11. Kinishi M, 2001, AURIS NASUS LARYNX, V28, P223, DOI 10.1016/S0385-8146(01)00055-4
  12. Murakami S, 1997, ANN NEUROL, V41, P353, DOI 10.1002/ana.410410310
  13. Ryu EW, 2012, AM J OTOLARYNG, V33, P313, DOI 10.1016/j.amjoto.2011.10.001
  14. Shim HJ, 2011, ACTA OTO-LARYNGOL, V131, P210, DOI 10.3109/00016489.2010.520167
  15. Sweeney CJ, 2001, J NEUROL NEUROSUR PS, V71, P149, DOI 10.1136/jnnp.71.2.149
  16. TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451
  17. Uri N, 2003, OTOLARYNG HEAD NECK, V129, P379, DOI 10.1016/S0194-5998(03)01305-6
  18. Yeo SW, 2007, AURIS NASUS LARYNX, V34, P159, DOI 10.1016/j.anl.2006.09.005
  19. Zainine R, 2012, Head and Neck Dis, V129, P22

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICHC